Erratum: T cells from patients with Parkinson’s disease recognize α-synuclein peptides

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature

• Publication date

  2017-09-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature23896PMID 28905919PMCID PMC10204083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T cells of Parkinson’s disease patients recognize α–synuclein peptides

  2017cited by this paper

• Immune Conversations Gone Wrong: Crosstalk Mechanisms Driving Alzheimer’s, Parkinson’s, and Depression

  2025cites this paper
• Design of a Multi‐Epitope Vaccine Targeting α‐Synuclein for Parkinson's Disease Using Immunoinformatics Tools

  2025cites this paper
• Multi-Omics Analysis Reveals the Protective Role of Transcriptional Enhancer Factor and the Pathogenic Mechanism of Monocytes in Parkinson's Disease.

  2025cites this paper
• Granzyme K+ CD8 T cells slow tauopathy progression by targeting microglia

  2025cites this paper
• Neuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes

  2025cites this paper
• (Dys)regulation of the Immune System in Parkinson’s Disease: Methodologies, Techniques, and Key Findings from Human Studies

  2025cites this paper
• Neuronal guidance signaling in neurodegenerative diseases: Key regulators that function at neuron-glia and neuroimmune interfaces

  2025cites this paper
• Bridging the gap in Parkinson’s disease research: from general pathophysiology to advanced 3d cell culture models

  2025cites this paper
• PINK1 is a target of T cell responses in Parkinson’s disease

  2024influential citation
• A general system for targeting MHC class II–antigen complex via a single adaptable loop

  2024cites this paper
• Association of Autoimmune Diseases with the Risk of Parkinson’s Disease

  2024cites this paper
• Peripheral endotoxin exposure in mice activates crosstalk between phagocytes in the brain and periphery

  2024cites this paper
• Overexpression of solute carrier family 6 member 12 promotes cell injury in Parkinson's disease via MAPK signaling pathway.

  2024cites this paper
• The immune system in Parkinson's disease: what we know so far

  2024cites this paper
• Coexistence of Parkinson's disease and myasthenia gravis: A case report and literature review

  2024cites this paper
• The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology

  2024cites this paper
• Associative role of HLA-DRB1 as a protective factor for susceptibility and progression of Parkinson’s disease: a Chinese cross-sectional and longitudinal study

  2024cites this paper
• PINK1 is a target of T cell responses in Parkinson’s disease

  2024cites this paper
• A general platform for targeting MHC-II antigens via a single loop

  2024cites this paper
• Naringenin as a potent anti-amyloidogenic polyphenol against a-synuclein aggregation: a computational approach

  2024cites this paper
• Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities

  2023cites this paper
• Neurobiology of Aging

  2023cites this paper
• Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review)

  2023cites this paper
• α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil

  2023cites this paper
• Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond

  2023cites this paper
• Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease

  2023cites this paper
• The role of T-cell subpopulations in the pathogenesis and therapy of Parkinson's disease (literature review)

  2023influential citation
• The Common Denominators of Parkinson’s Disease Pathogenesis and Methamphetamine Abuse

  2023cites this paper
• Bioinformatics analysis of potential common pathogenic mechanism for carotid atherosclerosis and Parkinson’s disease

  2023cites this paper
• CCR3 plays a role in murine age-related cognitive changes and T-cell infiltration into the brain

  2023cites this paper
• Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

  2023cites this paper
• Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson’s disease: an 8-year follow-up study

  2023cites this paper
• Ferroptosis: A potential therapeutic target in autoimmune disease (Review)

  2023cites this paper
• Differentiated Embryo-Chondrocyte Expressed Gene1 and Parkinson’s Disease: New Insights and Therapeutic Perspectives

  2023cites this paper
• Effects of a Small-Molecule Perforin Inhibitor in a Mouse Model of CD8 T Cell–Mediated Neuroinflammation

  2023cites this paper
• Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease

  2023cites this paper
• Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD

  2023cites this paper
• B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression

  2023cites this paper
• Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.

  2022cites this paper
• Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease.

  2022cites this paper
• T cells, α-synuclein and Parkinson disease.

  2022cites this paper
• Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders

  2022cites this paper
• Neuronal Presentation of Antigen and Its Possible Role in Parkinson’s Disease

  2022cites this paper
• T Lymphocytes in Parkinson’s Disease

  2022cites this paper
• Immune responses in the Parkinson ’ s disease brain Neurobiology of Disease

  2022cites this paper
• Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?

  2022cites this paper
• The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells.

  2022cites this paper
• Immunogenetic Determinants of Parkinson’s Disease Etiology

  2022cites this paper
• Tissue-resident CD8+ T cells drive compartmentalized and chronic autoimmune damage against CNS neurons

  2022cites this paper
• Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.

  2022cites this paper
• Inflammatory Animal Models of Parkinson’s Disease

  2022cites this paper
• Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies

  2022cites this paper
• Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B

  2022cites this paper
• Genetics and Pathogenesis of Parkinson’s Syndrome

  2022cites this paper
• Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences

  2022cites this paper
• Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition

  2022cites this paper
• The complex role of inflammation and gliotransmitters in Parkinson's disease.

  2022cites this paper
• Emerging point‐of‐care autologous cellular therapy using adipose‐derived stromal vascular fraction for neurodegenerative diseases

  2022cites this paper
• Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 Sequences

  2022cites this paper
• Protective effects of HLA-DRB1*04 subtypes in Parkinson's and Alzheimer's diseases implicate acetylated Tau PHF6 sequences

  2021cites this paper
• Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents

  2021cites this paper
• The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease

  2021cites this paper
• Immunogenetic Epidemiology of Dementia and Parkinson’s Disease in 14 Continental European Countries: Shared Human Leukocyte Antigen (HLA) Profiles

  2021cites this paper
• Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

  2021cites this paper
• The role of T cells in age-related diseases

  2021cites this paper
• Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases

  2021cites this paper
• Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal—Intestinal Inflammation Activited and Intestinal Microbiota—Metabolic Disorders Induced in MPTP Mouse Model of Parkinson’s Disease

  2021cites this paper
• Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases

  2021cites this paper
• Neurodegenerative Disease and the NLRP3 Inflammasome

  2021cites this paper
• High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases

  2021cites this paper
• Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies

  2021cites this paper
• Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.

  2020cites this paper
• Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease

  2020cites this paper
• Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells

  2020cites this paper
• Fine mapping of the HLA locus in Parkinson’s disease in Europeans

  2020influential citation
• Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment

  2020cites this paper
• Sexual Steroids and their Receptors Affect Microglia-Mediated Neuroinflammation in Neurodegenerative Diseases

  2020cites this paper
• Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease

  2020cites this paper
• Immunogenetics of Parkinson's disease: Translational studies from rodents to humans

  2019influential citation
• Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.

  2019cites this paper
• Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

  2019cites this paper
• Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson's Disease in vitro.

  2019cites this paper
• Deciphering the role of the gut microbiome in autoimmune thyroid disease

  2019cites this paper
• Genetic risk factors in Parkinson’s disease

  2018cites this paper
• HLA variation and disease

  2018cites this paper
• Therapies to Slow, Stop, or Reverse Parkinson’s Disease

  2018cites this paper
• Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives

  2018cites this paper
• Converging pathways in neurodegeneration, from genetics to mechanisms

  2018cites this paper
• Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson’s disease

  2018cites this paper
• Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease

  2018cites this paper
• LRRK2 Phosphorylation: Behind the Scenes

  2018cites this paper
• Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014

  2018cites this paper
• Understanding the role of perivascular macrophages in Parkinson's disease pathophysiology

  2017cites this paper
• HLA Class I or Class II and Disease Association: Catch the Difference If You Can

  2017cites this paper
• Therapeutic approaches to target alpha-synuclein pathology.

  2017cites this paper
• Becker Digital Commons

  year unknowninfluential citation
• Infectious agents as potential drivers of alpha-synucleinopathies

  year unknowncites this paper
• Elucidating the Multitrait Association between Parkinson’s Disease and Respiratory Disorders: HLA gene complex as a causal nexus

  year unknowncites this paper